Stephan Widensohler - St Jude Independent Director

Director

Mr. Stefan K. Widensohler was appointed as Independent Director of St. Jude Medical Inc. effective July 19 2013. Previously served as a Director of St. Jude Medical from 2001 to 2010. Since 1992 President and Chief Executive Officer of KRAUTH Medical Group which before 2012 was a European distributor of medical and surgical devices and services and which now invests in healthcare startup companies. Executive Vice President Global Sales and Marketing of Invatec SpA an Italian medical device company specializing in cardiology and peripheral vascular products from 1996 to 2010 and Vice President Global Sales after its acquisition by Medtronic Inc. from 2010 to 2012. Director of LDR Holdings Corporation a global medical device company since May 2006. since 2013.
Age 53
Tenure 11 years
Phone651 756-3301
Webwww.sjm.com

St Jude Management Efficiency

St Jude's management efficiency ratios could be used to measure how well St Jude manages its routine affairs as well as how well it operates its assets and liabilities.
The company has 6.39 B in debt with debt to equity (D/E) ratio of 1.29, which is OK given its current industry classification. St Jude Medical has a current ratio of 1.89, which is typical for the industry and considered as normal. Debt can assist St Jude until it has trouble settling it off, either with new capital or with free cash flow. So, St Jude's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like St Jude Medical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for STJ to invest in growth at high rates of return. When we think about St Jude's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Martin GlynnSun Life Financial
68
Karen FrancisThe Hanover Insurance
52
Michael WilkinsQBE Insurance Group
N/A
James PeckhasSun Life Financial
N/A
Patrick ReganQBE Insurance Group
52
Christopher McCormickSun Life Financial
61
Margaret HarrisSun Life Financial
63
Joseph RamrathThe Hanover Insurance
64
Theodore BuntingThe Hanover Insurance
62
Stephen FitzgeraldQBE Insurance Group
53
Dawn LaiSun Life Financial
N/A
Marielucie MorinSun Life Financial
63
Michael HarrisGetty Images Holdings
43
Jann SkinnerQBE Insurance Group
59
Kathryn LissonQBE Insurance Group
66
J CondrinThe Hanover Insurance
59
Sara LewisSun Life Financial
52
Real RaymondSun Life Financial
66
Rolf TolleQBE Insurance Group
68
Michael PriceThe Hanover Insurance
52
Wendell KnoxThe Hanover Insurance
73
St. Jude Medical, Inc., together with its subsidiaries, develops, manufactures, and distributes cardiovascular medical devices for cardiac rhythm management, cardiovascular, and atrial fibrillation therapy areas worldwide. St Jude Medical (STJ) is traded on New York Stock Exchange in USA and employs 18,000 people.

Management Performance

St Jude Medical Leadership Team

Elected by the shareholders, the St Jude's board of directors comprises two types of representatives: St Jude inside directors who are chosen from within the company, and outside directors, selected externally and held independent of STJ. The board's role is to monitor St Jude's management team and ensure that shareholders' interests are well served. St Jude's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, St Jude's outside directors are responsible for providing unbiased perspectives on the board's policies.
David Lamb, Managing Director, Executive Director
Baroness Wheatcroft, Non-Executive Independent Director
Ian Gascoigne, Managing Director, Executive Director
John Heinmiller, Executive VP
Tony Dunk, Director - Investor Relations
Denis Gestin, President of International Division
Craig Gentle, CFO
Stephan Widensohler, Independent Director
Donald Zurbay, CFO and VP of Fin.
Lisa Andrade, Chief Marketing Officer
Wendy Yarno, Independent Director
Iain Cornish, Senior Independent Non-Executive Director
Richard Devenuti, Independent Director
Sarah Bates, Non-Executive Chairman of the Board
Jeffrey Dallager, Vice President Corporate Controller
Joel Becker, President - Americas Division
Stuart Essig, Independent Director
Andrew Croft, CFO, Executive Director
Barbara Hill, Independent Director
David Bellamy, Chief Executive, Executive Director
Roger Yates, Independent Non-Executive Director
John Brown, Independent Presiding Director
Daniel Starks, Executive Chairman
Eric Fain, Group President - St. Jude Medical
Elizabeth Kelly, Company Secretary
Rachel Ellingson, Vice President - Corporate Relations
Mark Carlson, Vice President - Global Clinical Affairs, Chief Medical Officer
Paul Bae, Chief Marketing Officer, Vice President - Global Human Resources
Michael Rousseau, CEO and President COO and Director
Mark Murphy, CIO and VP of Information Technology
Scott Thome, Vice President - Global Operations and Supply Chain
Michael Rocca, Independent Director
Simon Jeffreys, Independent Non-Executive Director
Jeff Fecho, Vice President - Global Quality
Jason Zellers, Vice President General Counsel, Corporate Secretary
J Weigelt, Director - Investor Relations
David Dvorak, Director
Robert Gardner, Director of Investment Management
Stefan Widensohler, Independent Director

STJ Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is St Jude a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Consideration for investing in STJ Stock

If you are still planning to invest in St Jude Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the St Jude's history and understand the potential risks before investing.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Money Managers
Screen money managers from public funds and ETFs managed around the world
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world